Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options-Reference-Cited by-同舟云学术

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

Published:2018-04 Issue:4 Volume:199 Page:990-997
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sanda Martin G.¹²³,Cadeddu Jeffrey A.¹²³,Kirkby Erin¹²³,Chen Ronald C.¹²³,Crispino Tony¹²³,Fontanarosa Joann¹²³,Freedland Stephen J.¹²³,Greene Kirsten¹²³,Klotz Laurence H.¹²³,Makarov Danil V.¹²³,Nelson Joel B.¹²³,Rodrigues George¹²³,Sandler Howard M.¹²³,Taplin Mary Ellen¹²³,Treadwell Jonathan R.¹²³

Affiliation:

1. American Urological Association Education and Research, Inc., Linthicum, Maryland

2. ASTRO, Arlington, Virginia

3. Society of Urologic Oncology, Schamburg, Illinois

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference36 articles.

1. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

2. Timing of adverse prostate cancer reclassification on first surveillance biopsy: results from the Canary Prostate Cancer Active Surveillance Study;Macleod;J Urol,2017

3. Long term survival and predictors of disease reclassification in patients on an active surveillance protocol for prostate cancer;Agarwal;Can J Urol,2016

4. Is it time to revisit the role of prostate-specific antigen kinetics in active surveillance for prostate cancer?;Iremashvili;Urology,2016

5. Radical prostatectomy versus observation for localized prostate cancer;Wilt;N Engl J Med,2012

Cited by 299 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer;Clinical Genitourinary Cancer;2024-12

2. MRI and active surveillance: thoughts from across the pond;European Radiology;2024-09-12

3. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25

4. Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal Status;European Urology Oncology;2024-08

5. Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage;Histopathology;2024-06-03